StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.50−0.01 (-2.64%)

Close on Nov 19, 2026Market cap $13.65MP/E –Yield –

Citius Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Citius Pharmaceuticals's free cash flow for the twelve months ending Sep 30, 2021 was -$24.26M. For fiscal 2021 it was -$24.26M.

Annual free cash flow

PeriodPeriod endValueChange
FY2021Sep 30, 2021-$24.26M–
FY2020Sep 30, 2020-$16.93M–
FY2017Sep 30, 2017-$7.97M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2021CQ3 2021Sep 30, 2021-$5.59M–
Q4 FY2020CQ3 2020Sep 30, 2020-$3.36M–

More Citius Pharmaceuticals figures

See a number that looks wrong?